Role of mast cell in hyperalgesic priming and the preventive effect of electroacupuncture on the transition from acute to chronic pain

Acupuncture and Herbal Medicine ›› 2024, Vol. 4 ›› Issue (4) : 525-537.

PDF(3437 KB)
PDF(3437 KB)
Acupuncture and Herbal Medicine ›› 2024, Vol. 4 ›› Issue (4) : 525-537. DOI: 10.1097/HM9.0000000000000140
research-article

作者信息 +

Role of mast cell in hyperalgesic priming and the preventive effect of electroacupuncture on the transition from acute to chronic pain

Author information +
History +

Abstract

Objective: Injury can lead to long-term changes that increase the sensitivity of afferent nerve endings to subsequent stimulation and pain can transition from acute to chronic. This phenomenon is known as hyperalgesic priming (HP). This study aimed to understand the mechanisms underlying the effect of electroacupuncture (EA) on HP and optimize acupoint selection for EA to prevent pain transition.
Methods: A rat HP model was established using sequential intraplantar injections of carrageenan (Cg) and prostaglandin E2 (PGE2). The pain thresholds were measured using von Frey filaments. EA on bilateral Zusanli (ST36) and Kunlun (BL60) was used to prevent pain transition. The number of mast cells in the ipsilateral hindpaw skin was determined using toluidine blue or fluorescence-labeled avidin staining. The protein expression levels of protein kinase C epsilon (PKCε) in the lumbar dorsal root ganglions (DRGs) were detected by western blotting 24 h after PGE2 injection. Serial pharmacological experiments were conducted to evaluate the relationship between mast cells and pain transition. Finally, EA on the bilateral ST36 and Chongyang (ST42) or a novel combination (ST36 and ST42 on the ipsilateral side, and ST36 and BL60 on the contralateral side) was used to prevent pain transition.
Results: Although EA applied to ST36 and BL60 alleviated acute pain induced by Cg injection, it failed to prevent the pain transition caused by PGE2 injection. Mast cell accumulation in the ipsilateral hind paw was observed 7 days after Cg injection. Furthermore, mast cell degranulation may be responsible for PKCε activation in the DRG, a marker of pain transition. EA significantly decreased the number of mast cells in the skin of the ipsilateral hind paw when applied at ST36 and ST42, but not when applied at ST36 and BL60. Furthermore, EA employed to ST36 and ST42 significantly reversed long-term hyperalgesia induced by PGE2 injection, even when administered before injection. However, EA did not alleviate acute pain caused by Cg injection. By using a novel acupoint combination, EA simultaneously alleviated acute pain and prevented pain transition.
Conclusions: Our study suggests that mast cells play a critical role in both HP and the transition from acute to chronic pain, whereas EA can prevent pain transition by decreasing the number of mast cells in the local tissue.

Keywords

Acupoints / Electroacupuncture / Hyperalgesic priming / Mast cell / PAR2

引用本文

导出引用
. . Acupuncture and Herbal Medicine. 2024, 4(4): 525-537 https://doi.org/10.1097/HM9.0000000000000140

参考文献

[[1]]
Price TJ, Basbaum AI, Bresnahan J, et al. Transition to chronic pain: opportunities for novel therapeutics. Nat Rev Neurosci. 2018;19(7):383-384.
[[2]]
Joseph EK, Parada CA, Levine JD. Hyperalgesic priming in the rat demonstrates marked sexual dimorphism. Pain. 2003;105(1-2):143-150.
[[3]]
Kandasamy R, Price TJ. The pharmacology of nociceptor priming. Handb Exp Pharmacol. 2015;227:15-37.
[[4]]
Eller-Smith OC, Nicol AL, Christianson JA. Potential mechanisms underlying centralized pain and emerging therapeutic interventions. Front Cell Neurosci. 2018;12:35.
[[5]]
Parada CA, Yeh JJ, Reichling DB, et al. Transient attenuation of protein kinase C epsilon can terminate a chronic hyperalgesic state in the rat. Neuroscience. 2003;120(1):219-226.
[[6]]
Han JS. Acupuncture and endorphins. Neurosci Lett. 2004;361(1-3):258-261.
[[7]]
Liu J. Research on mechanisms of acupuncture analgesia—the most impressive field of acupuncture medicine. World [J] Acupunct Moxibustion. 2023;33(1):3-5.
[[8]]
Wang S, Du J, Shao F, et al. Electroacupuncture regulates pain transition by inhibiting the mGluR5-PKCε signaling pathway in the dorsal root ganglia. [J] Pain Res. 2020;13:1471-1483.
[[9]]
Fang J, Wang S, Zhou J, et al. Electroacupuncture regulates pain transition through inhibiting PKCε and TRPV1 expression in dorsal root ganglion. Front Neurosci. 2021;15:685715.
[[10]]
Liang Y, Zhou J, Sun J, et al. The dose-effect relationship of electroacupuncture analgesia and its stimulus parameters: progress in the last 3 decades. World [J] Acupunct Moxibustion. 2023;33(1):12-19.
[[11]]
Wang S, Du J, Xi D, et al. Role of GABAAR in the transition from acute to chronic pain and the analgesic effect of electroacupuncture on hyperalgesic priming model rats. Front Neurosci. 2021;15:691455.
[[12]]
Tillu DV, Hassler SN, Burgos-Vega CC, et al. Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state. Pain. 2015;156(5):859-867.
[[13]]
Bao Y, Hou W, Hua B. Protease-activated receptor 2 signalling pathways: a role in pain processing. Expert Opin Ther Targets. 2014;18(1):15-27.
[[14]]
Zhang M, Gao CX, Wang YP, et al. The association between the expression of PAR2 and TMEM16A and neuropathic pain. Mol Med Rep. 2018;17(3):3744-3750.
[[15]]
Noh CS, Chung HY, Han IH, et al. Mast cell tryptase-PAR2 pathway in proliferation of prostatic stromal cells reacted with Trichomonas vaginalis. Parasite Immunol. 2021;43(8):e12868.
[[16]]
Green DP, Limjunyawong N, Gour N, et al. A mast-cell-specific receptor mediates neurogenic inflammation and pain. Neuron.2019;101(3):412-420.e3.
[[17]]
Theoharides TC, Tsilioni I, Bawazeer M. Mast cells, neuroinflammation and pain in fibromyalgia syndrome. Front Cell Neurosci. 2019;13:353.
[[18]]
Voss M, Kotrba J, Gaffal E, et al. Mast cells in the skin: defenders of integrity or offenders in inflammation? Int [J] Mol Sci. 2021;22(9):4589.
[[19]]
Lopes DM, Denk F, Chisholm KI, et al. Peripheral inflammatory pain sensitisation is independent of mast cell activation in male mice. Pain. 2017;158(7):1314-1322.
[[20]]
Magnúsdóttir EI, Grujic M, Roers A, et al. Mouse mast cells and mast cell proteases do not play a significant role in acute tissue injury pain induced by formalin. Mol Pain. 2018;14:1744806918808161.
[[21]]
Kawahara K, Hohjoh H, Inazumi T, et al. Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors. Biochim Biophys Acta. 2015;1851(4):414-421.
[[22]]
Li N, Guo Y, Gong Y, et al. The anti-inflammatory actions and mechanisms of acupuncture from acupoint to target organs via neuro-immune regulation. [J] Inflamm Res. 2021;14:7191-7224.
[[23]]
Yang M, Ma Y, Tao S, et al. Mast cell degranulation promotes ischemia-reperfusion injury in rat liver. [J] Surg Res. 2014;186(1):170-178.
[[24]]
Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. [J] Neurosci Methods. 1994;53(1):55-63.
[[25]]
Ren SR, Xu LB, Wu ZY, et al. Exogenous dendritic cell homing to draining lymph nodes can be boosted by mast cell degranulation. Cell Immunol. 2010;263(2):204-211.
[[26]]
Sun H, Li X, Wang S, et al. Intervention mechanism of electroacupuncture on the EP1-TRPV1 pathway in the dorsal root ganglion of rats in the transition from acute to chronic pain. World [J] Acupunct Moxibustion. 2023;33(1):34-43.
[[27]]
Joseph EK, Levine JD. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. Neuroscience. 2010;169(1):431-435.
[[28]]
Ferrari LF, Bogen O, Levine JD. Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat. [J] Pain. 2014;15(3):312-320.
[[29]]
Schemann M, Kugler EM, Buhner S, et al. The mast cell degranulator compound 48/80 directly activates neurons. PLoS One. 2012;7(12):e52104.
[[30]]
Li Y, Yu Y, Liu Y, et al. Mast cells and acupuncture analgesia. Cells. 2022;11(5):860.
[[31]]
Gupta K, Harvima IT. Mast cell-neural interactions contribute to pain and itch. Immunol Rev. 2018;282(1):168-187.
[[32]]
Héron A, Dubayle D. A focus on mast cells and pain. [J] Neuroimmunol. 2013;264(1-2):1-7.
[[33]]
Dai Y, Wang S, Tominaga M, et al. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. [J] Clin Invest. 2007;117(7):1979-1987.
[[34]]
Wang S, Dai Y, Kobayashi K, et al. Potentiation of the P2X3 ATP receptor by PAR-2 in rat dorsal root ganglia neurons, through protein kinase-dependent mechanisms, contributes to inflammatory pain. Eur [J] Neurosci. 2012;36(3):2293-2301.
[[35]]
Bunnett NW. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Thromb Hemost. 2006;32(Suppl 1):39-48.
[[36]]
Fang J, Wang S, Sun H, et al. Effect of inhibition of PAR2-PKA/PKCε signaling pathway in periphery neurons on the transition from acute to chronic pain. Chin [J] Exp Anim. 2018;26(1):13-19.
[[37]]
Chen Y, Yang C, Wang ZJ. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience. 2011;193:440-451.
[[38]]
Amadesi S, Cottrell GS, Divino L, et al. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase C epsilon- and A-dependent mechanisms in rats and mice. [J] Physiol. 2006;575(Pt 2):555-571.
[[39]]
Akita Y. Protein kinase C-epsilon (PKC-epsilon): its unique structure and function. J Biochem (Tokyo). 2002;132(6):847-852.

版权

2024 Acupuncture and Herbal Medicine
PDF(3437 KB)

Accesses

Citation

Detail

段落导航
相关文章

/